LightForce EXP LTS-1500PRecalls & reported problems
Litecure LLC · Mains powered, infrared and nail laser phototherapy device emitting up to 15 W at 810 & 980 nm and up to 25 W at 980 nm. At 810 & 980 nm, the LightForce EXP (LTS-1500P) is indicated for emitting energy in the infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for temporary relief of minor muscle and joint pain, muscle spasm, pain and stiffness associated with arthritis and promoting relaxation of the muscle tissue and to temporarily increase local blood circulation. At 980 nm, the EXP is indicated for use for the temporary increase of clear nail in patients with onychomycosis (e.g. dermatophytes, Trichophyton rubrum and Tmentagrophytes, and/or yeasts Candida albicans, etc.). The EXP is a portable medical laser therapy system. The laser light delivery system consists of a flexible optical fiber threaded through a lightweight hand piece. Activation occurs when the operator enables the laser and presses the finger switch, or optional foot switch. Depending on laser system configuration, the finger switch can function as an on/off switch. A touch-screen display panel allows the operator to adjust or set laser output level. The laser can operate in continuous wave mode or controlled pulse mode. · Class 2
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00854103007035), received between Nov 10, 2017 and Nov 10, 2017 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Injury1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryNov 10, 2017Adverse Event Without Identified Device or Use Problem
INITIAL REPORT INDICATED A DIABETIC PATIENT OF AN ORTHOPEDIC AND SPORTS MEDICINE CLINIC SUFFERED A POTENTIAL TOE INJURY AND A LITECURE THERAPY LASER DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THIS INJURY. IN FOLLOW UP COMMUNICATIONS WITH THE PRACTICE, THE LITECURE REPRESENTATIVE RETRACTED DETAILS REGARDING THE LOCATION OF THE INJURY STATING IT WAS AN ASSUMPTION HE MADE AND THAT A BODY PART WAS NOT SPECIFICALLY MENTIONED TO HIM BY THE DOCTOR, BUT THAT TYPE OF INJURY COULD HAPPEN IN THE FOOT AREA WHERE DIABETICS TYPICALLY SUFFER FROM NEUROPATHY. THE SEVERITY OF THE INJURY IS UNKNOWN AND THE LOCATION HAS NOT BEEN CONFIRMED.
Patient problems: Injury
MAUDE report 7019547 ↗
Other Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis devices
- LightForce EXPi LTS-2500Litecure LLC · Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.